Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board

James E. Udelson MD Advisory Board

See All Experts

featured

Published in Cardiology

Journal Scan / Research · October 10, 2024

Effects of Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Patients With Heart Failure

Circulation

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Efficacy and Safety of Finerenone Across the LVEF Spectrum in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Disclosure statements are available on the authors' profiles:

Kieran Docherty MB ChB, PhD

Giselle Suero-Abreu MD, PhD, MSc

Circulation

Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure

Circulation 2024 Sep 28;[EPub Ahead of Print], M Vaduganathan, BL Claggett, IJ Kulac, ZM Miao, AS Desai, PS Jhund, AD Henderson, M Brinker, J Lay-Flurrie, P Viswanathan, MF Scheerer, A Lage, CSP Lam, M Senni, SJ Shah, AA Voors, F Zannad, B Pitt, JJV McMurray, SD Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Patients With Heart Failure

Additional Info

Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure

Further Reading

Mediterranean Diet, Neutrophil Count, and Carotid Intima-Media Thickness in Secondary Prevention

Post-MI Outcomes After First-Line Ablation in Patients With Tolerated VT and an LVEF >35%

Transesophageal 3D Echocardiographic Guidance for Pacemaker Lead Placement

Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome

Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle–Psychological Factors

Long-Term Prognosis of Coronary Aneurysms

Using Electrocardiography to Assess Diastolic Function and Prognosis in Mitral Regurgitation

TAVI and FFR-Guided PCI vs Conventional Surgical Aortic Valve Replacement and CABG for Patients With Aortic Valve Stenosis and Complex or Multivessel Coronary Disease

Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for Initial Treatment of Hypertension

Twofold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis

Machine Learning–Based Prediction of Death and Hospitalization in Patients With ICDs

Recently Updated